DRUG STUDY

Medication (include dosage, route & frequency)Drug ClassificationIndicationMechanism of ActionSide effects/Adverse ReactionsNursing ResponsibilitiesContraindications and Cautions

Ambroxol0.5 TID

Mucolytic

Adjuvant therapy in patients with abnormal, viscid, or in spissated mucous secretions in acute and chronic bronchopulmonary diseases, and in pulmonary complications of cystic fibrosis and surgery, tracheostomy, and atelectasis.

It makes phlegm in the airways thinner and less sticky. It does this by increasing the body's natural production of surfactant. This contributes to a secretomotoric effect: it helps the cilia - tiny hairs that line the respiratory tract - to transport the phlegm out of the lungs. Here is a step-by-step description of how Ambroxol works:

Occasional gastrointestinal side effects may occur but these are almost invariably mild.

Monitor S/Sx of aspiration of excess secretions and for bronchospasm . Monitor ABGs, pulmonary functions and pulse oximetry as indicated. Have suction apparatus immediately available. Report difficulty with clearing the airway or any other respiratory distress.

There is no absolute contraindication but in patients with gastric ulceration relative caution should be observed.